SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Results of Operations for Reportable Segment

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Year Ended December 31,
	2024		2023		2022
Infusion services net revenue	$	4,911,591	$	4,222,656	$	3,869,036
Other revenue (1)	86,611		79,668		$	75,699
Total Option Care Health revenue	4,998,202		4,302,324		$	3,944,735
(Expense) Income:
Cost of net revenues - drugs	(3,446,735)		(2,812,531)		$	(2,562,494)
Salaries, benefits, and other employee expense	(787,922)		(760,499)		$	(709,916)
Other segment items (2)	(380,803)		(355,498)		$	(371,529)
Depreciation and amortization expense	(60,909)		(59,201)		$	(60,565)
Interest expense, net	(49,029)		(51,248)		$	(53,806)
Equity in earnings of joint ventures	5,964		5,530		$	5,125
Other, net	4,831		89,865		$	14,218
Income tax expense	(71,776)		(91,652)		$	(55,212)
Net Income	$	211,823	$	267,090	$	150,556

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.